The drug, reproxalap, led to reductions in symptoms of dry eye, but regulators have repeatedly refused to approve it for this ...

Richard Adler, MD, FACS, provides perspective on AAO 2023 data suggesting dual mechanism treatment targeting aqueous deficiency and meibomian gland dysfunction may improve dry eye symptoms more ...

TAMPA, Fla., Dec. 11, 2023 /PRNewswire/ -- Amidst the demand for innovative dry eye solutions, a groundbreaking collaboration between distinguished scientists and healthcare experts has been published ...

Eye symptoms affect most recipients of lash lifts and extensions, with an independent association with dry eye in an ...

Dry eye disease (DED) is a prevalent, chronic condition diagnosed in about 16.4 million Americans, with an additional 6 million undiagnosed patients experiencing dry eye symptoms. 1 The prevalence of ...

Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

Dry eye care is entering a transformative phase, with novel drugs, biologics, and devices promising faster relief and more personalized treatment. While some therapies like reproxalap show strong ...

Dry eye disease is a multifactorial disease characterized by a loss of homeostasis on the ocular surface. Patients with dry ...

Please provide your email address to receive an email when new articles are posted on . The TRPM8 receptor agonist increases natural tear production as early as day 1. Alcon also launched a campaign ...

Burning, itching, watering eyes. Few things are a bigger nuisance than irritated eyes, so it's no surprise there are so many options for dry eye relief. While various treatment options are available ...

“Discomfort created by the condition causes substantial physical, financial and psychological consequences,” Bai said. “The grant will allow us to use the technology that Dr. Nichols and I created to ...